2010 NHIA Annual Conference & Exposition

Clinical Track

Supported by an unrestricted educational grant from Hospira Worldwide, Inc.
 hospira

Monday, April 12

1:45 – 3:15 p.m.

clinical1-A. Extended Stability and Beyond-Use Dating in Home Infusion—A Critical Piece of the USP <797> Compliance Puzzle

 

Faculty: Caryn Marie Dellamorte Bing, RPh, MS, FASHP, Clinical Services & Residency Program Manager, Critical Care Systems, Las Vegas, NV

Continuing Education Contact Hours:
Pharmacy and Nursing—1.5
ACPE #
VNA#

  • Understand the relationship between drug storage time frames and compounded sterile product (CSP) risk levels, as outlined in the United States Pharmacopeia’s (USP) Chapter <797>.
  • Comprehend the process for assigning beyond-use dating when USP <797> specifications are exceeded.
  • Reflect upon key considerations and strategies for maintaining CSP integrity throughout the compounding, distribution and administration processes.

Objectives:

  1. Discuss the storage time frames for each USP Chapter 797 risk level for compounded sterile preparations (CSPs).
  2. Describe processes required for assigning beyond use dates to CSP’s that exceed the USP Chapter 797 specifications.
  3. Describe key points for maintaining compounded sterile preparation (CSP) integrity in the compounding and distribution process.

Tuesday, April 13

10:45 – 11:45 a.m.

clinical5-B. Home Sweet Home—Safe and Effective Infusion Therapy for the Pediatric Patient

 

Faculty: Mary Worthington, PharmD, BCPS, Associate Professor of Pharmacy Practice & Pediatric Clinical Pharmacy Specialist, Samford University, Birmingham, AL

Continuing Education Contact Hours:
Pharmacy and Nursing — 1.0
ACPE #
VNA#

  • Explore the physiological, social and developmental considerations required for safe and effective delivery of pediatric infusion care.
  • Review dose, volume and administration core-concepts for the full age-range of patients in the “pediatric” category.
  • Identify the most common medication errors made in the care of children—and strategize how they can be avoided in the home setting.

Objectives:

  1. Discuss developmental considerations related to the management of pediatric home infusion patients.
  2. Discuss pediatric parenteral drug administration considerations related to dose, volume, and administration device.
  3. List the most common causes for medication errors in children and describe strategies to prevent these errors.

3:15 – 4:45 p.m.

clinical9-C. New Parenteral Drugs 2009: A Review for the Home Care and Ambulatory Infusion Center Practitioner

 

Faculty: Anna Nowobilski-Vasilios, PharmD, MBA, FASHP, CNSC, BCNSP, Principal, Anovation, Chicago, IL

Continuing Education Contact Hours:
Pharmacy and Nursing — 1.5
ACPE #
VNA#

  • Hear critical updates regarding the new parenteral drugs and biologic agents that entered the market in 2009—and the most promising drugs in the pipeline.
  • Understand the patient education and clinical monitoring considerations essential for achieving therapeutic goals with each new drug.
  • Grasp the major adverse effects and contraindications of the new agents, as you learn how they are dosed, administered and stored.

Objectives:

  1. Highlight the pathophysiology and therapeutic goals for each corresponding disease state.
  2. Discuss the indications and appropriate role of each new agent.
  3. Discuss patient education and monitoring interventions that would lead to achievement of therapeutic goals.
  4. Describe the major adverse effects, contraindications, and precautions for new agent.
  5. List issues related to dosing, administration, and storage for each new agent.

Wednesday, April 14

10:45 a.m. – 12:15 p.m.

clinical13-D. Resolving Ethical Dilemmas in the Alternate-Site Setting

 

 

Faculty: Barbara Schlienz-Prosser, RPh, Vice President, Clinical Services, Critical Care Systems, Nashua, NH

Continuing Education Contact Hours:
Pharmacy and Nursing — 1.5
ACPE #
VNA#

  • Examine ethical matters that present a challenge in the alternate-site setting.
  • Review case studies of ethical issues involving alternate-site employees and patients.
  • Devise a framework for the systematic analysis and resolution of ethical dilemmas.

Objectives:

  1. Describe problematic ethical issues associated with alternate site care.
  2. Describe the role of the supervisor in assuring ethical employee behavior.
  3. Develop a framework for the systematic analysis of ethical patient care issues in home care.

2:45 – 3:45 p.m.

clinical17-E. Providing Home Infusion for the Patient with Compromised Renal Function

 

Faculty: Carol Rollins, MS, RD, CNSD, PharmD, BCNSP, Interim Assistant Director, Clinical Pharmacy Services, University Medical Center, Tucson, AZ

Continuing Education Contact Hours:
Pharmacy and Nursing — 1.0
ACPE #
VNA#

  • Grasp the impact of kidney function on the overall health of your patients—and on their response to infusion therapy.
  • Explore the continuum of renal dysfunction, from diagnosis to treatment.
  • Identify the home infusion therapies most impacted by, or affecting, renal function—and ascertain how best to formulate a plan of care for your patient.

Objectives:

  1. Discuss the continuum of renal impairment from insufficiency to failure.
  2. Describe the impact of renal function on management of home infusion therapies.
  3. List the home infusion therapies with the potential to impact renal function.

Thursday, April 15

9:00 – 11:00 a.m.

clinical21-F. Examining Care of Clinically Complex Patients in the Home

 

 

Faculty: Pammi J. Farren, RPh, PhD, Branch Infusion Manager, Coram Infusion Services, An Apria Healthcare Company, Columbus, OH

Continuing Education Contact Hours:
Pharmacy and Nursing — 2.0
ACPE #
VNA#

  • Evaluate a systematic approach for safe and effective care of clinically complex patients in the home.
  • Participate in an interactive care planning session—problem-solving the care of a heart failure patient with a complicated medical condition and a patient with challenging pain management needs.
  • Devise a process that promotes the safe initiation of care in the home when information about the prescribed medication is limited.

Objectives:

  1. Develop a systematic approach to initiation of home infusion for clinically unique or challenging patient cases.
  2. Describe methods to improve patient outcomes through effective intra- and interdisciplinary communication.
  3. Discuss the role/significance of continuity of care for patients with complex medical conditions. (heart failure/ multiple health concerns).
  4. Review key clinical and legal aspects of initiation of home infusion of pain medications.
  5. Apply the systematic approach to situations involving atypical dosing and limited drug information.

11:15 a.m. – 12:15 p.m.

clinical25-G. The Interdisciplinary Care Planning Process—Simplified!

 

 

Faculty: Donald J. Filibeck, PharmD, MBA, National Director, Pharmacy Services, Critical Care Systems, Dublin, OH; and Kevin L. Ross, RN, BSN, National Director, Nursing, Critical Care Systems, Bartonville, TX

Continuing Education Contact Hours:
Pharmacy and Nursing — 1.0
ACPE #
VNA#

  • Delve into the essential elements of a multi-disciplinary patient-centered plan of care.
  • Strategize how to build a care plan that functions as a guide for ongoing patient care, with input from all team members.
  • Engage in a guided case study exercise focused on building an effective plan of care.

Objectives:

  1. Define the key components of a successful interdisciplinary care plan.
  2. Discuss strategies for implementation of a dynamic care planning process, including case conferences.
  3. Formulate an interdisciplinary care plan, given a case study sample.

2:15 – 3:45 p.m.

clinical29-H. Essentials for Home Initiation of Parenteral Nutrition

 

 

Faculty: Carol Ireton-Jones, PhD, RD, LD, CNSD, FACN, Nutrition Therapy Specialist, Consultant in Private Practice, Carrollton, TX

Continuing Education Contact Hours:
Pharmacy and Nursing — 1.5
ACPE #
VNA#

  • Synthesize the many factors that influence initiation of parenteral nutrition (PN) in the home.
  • Comprehend the etiology of refeeding syndrome—and the steps that can be taken to reduce this risk following the introduction of PN.
  • Identify the monitoring parameters essential to safe and effective PN administration.

Objectives:

  1. Discuss admission criteria for initiation of PN in the home setting.
  2. Discuss causes and treatment of refeeding syndrome.
  3. List 5 specific monitoring parameters/interventions for the patient who initiates TPN in the home.